The serum level of CEA in the lung cancer group was higher than that in the benign lung disease group, but there were no significant differences in the level of IL-1β, IL-6, and IL-8 between the lung cancer group and the benign lung disease group. The gene discussed is CEACAM5; the disease is lung carcinoma.